Perioperative Management & Outcome Following Preoperative Transthoracic Echocardiography in Noncardiac Surgery Patients

European Society of Anaesthesiology

Status: Not yet enrolling

Conditions: Elective Surgical Procedure

Treatments: Other: Transthoracic Echocardiography Recieved

Study type: Observational

Funder types: Other

Identifiers

NCT06409234

EuPreCHO

Details and patient eligibility

About

In August 2022 the European Society of Cardiology published updated guidelines including recommendations on preoperative transthoracic echocardiography. The update resulted in broadened criteria for preoperative transthoracic echocardiography. The impact of preoperative transthoracic echocardiography on outcome is controversial and the evidence was mostly derived from administrative databases. Also there is also a knowledge gap in terms of what changes in perioperative managements are derived from transthoracic echocardiography information in current daily practice in Europe and what their impact on outcome may be. Further, a secondary analysis in a large international cohort suggests that the criteria endorsed by the guidelines to define the class of recommendation of transthoracic echocardiography may not be efficient.

Full description

The target population consists of patients at elevated cardiovascular risk undergoing elective, intermediate or high-risk noncardiac surgery. The planned sample size is 5500 exposed and 2750 non-exposed

Enrollment: 8,250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• aged ≥65 years OR
• above 18 years and presenting ≥2 cardiovascular risk factors (hypertension, smoking, dyslipidaemia, diabetes, family history of CVD) OR
• above 18 years with known cardiovascular disease

Exclusion Criteria

• under 18 years of age
• day surgery
• urgent/emergency procedures
• current ICU patient (i.e. in ICU on day-1 or the day of the index surgery (day 0)),
• cardiac surgery within the last month prior according to the index noncardiac procedure (of note this does not include cardiological interventions like TAVI or valvuloplasty),
• unwilling or unable to provide informed consent,
• unable to complete the WHODAS questionnaire (literacy or language barrier)
• Previous enrollment in EuPreCHO (in case of repeated surgery)

Trial design

8,250 participants in 1 patient group

Exposed group

Description:

5500 exposed group will be patients in whom Transthoracic Echocardiography was performed within 3 months before surgery. Controls will be patients in whom Transthoracic Echocardiography was NOT performed.

Treatment:

Other: Transthoracic Echocardiography Recieved